Fundraising FoxGENERAL INCEPTION — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Switchback Systems develops a benchtop DNA synthesis platform that combines onboard oligonucleotide synthesis and gene assembly, aimed at putting synthetic biology tools directly in scientists' hands.
BiotechDeep TechHardwareSan Francisco Bay Area, US
Mary Noe(Executive Officer, Director)in
BoardTimothy Richardson(Director)Paul Conley(Director)inA Craig Asher(Director)
Board seatCraig Asher· per SEC Form D
Co-investorsAhren Innovation CapitalVertical Venture PartnersOMX Ventures
Glyphic Biotechnologies develops ProSE™, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity.
BiotechDeep TechBerkeley, US
Daniel Estandian(Founder)inEd Boyden(Founder)Josh Yang(Founder)inJoshua Yang(Founder)
Board seatCraig Asher· per SEC Form D · $52.9M raise · filed Feb 2024
Co-investorsArtis VenturesBlack FlagCivilization Ventures Management, LlcFoundersX VenturesGaingelsHarpoon Ventures+10 more
__Twitter.png)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.